HMC

Serial Number 88070382
606

Registration Progress

Application Filed
Aug 8, 2018
Under Examination
May 14, 2019
Approved for Publication
Mar 19, 2019
Published for Opposition
Mar 19, 2019
Registered

Basic Information

Serial Number
88070382
Filing Date
August 8, 2018
Published for Opposition
March 19, 2019
Abandonment Date
June 20, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 20, 2022
Classes
001 005 042

Rights Holder

Astellas Institute for Regenerative Medicine

03
Address
33 Locke Drive
Marlborough, MA 01752

Ownership History

Astellas Institute for Regenerative Medicine

Original Applicant
03
Marlborough, MA

Astellas Institute for Regenerative Medicine

Owner at Publication
03
Marlborough, MA

Legal Representation

Attorney
Christian S. Morgan

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description
Jun 21, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 20, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Mar 30, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 30, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 30, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 28, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2021 EX5G S SOU EXTENSION 5 GRANTED
Oct 25, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 19, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 19, 2021 EXT5 S SOU EXTENSION 5 FILED
Mar 30, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 26, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 26, 2021 EXT4 S SOU EXTENSION 4 FILED
Mar 26, 2021 EX4G S SOU EXTENSION 4 GRANTED
Nov 10, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 6, 2020 EXT3 S SOU EXTENSION 3 FILED
Nov 6, 2020 EX3G S SOU EXTENSION 3 GRANTED
May 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
May 11, 2020 EXT2 S SOU EXTENSION 2 FILED
May 11, 2020 EX2G S SOU EXTENSION 2 GRANTED
Nov 15, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 13, 2019 EXT1 S SOU EXTENSION 1 FILED
Nov 13, 2019 EX1G S SOU EXTENSION 1 GRANTED
Nov 11, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 14, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 19, 2019 PUBO A PUBLISHED FOR OPPOSITION
Mar 19, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 27, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 14, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 12, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2019 ALIE A ASSIGNED TO LIE
Feb 7, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2018 CNRT R NON-FINAL ACTION WRITTEN
Aug 22, 2018 GNRT F NON-FINAL ACTION E-MAILED
Aug 22, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2018 DOCK D ASSIGNED TO EXAMINER
Aug 15, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Cells, cell extracts, components of cells and cell culture media for medical and scientific research
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Cells, cell extracts, components of cells and cell culture media for medical or clinical use for the treatment of a variety of human and animal diseases and conditions; pharmaceutical products for the treatment of degenerative diseases and disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders, and diseases and disorders of aging
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Biotechnology services, namely, medical and scientific research in the field of producing cell types, cell extracts, components of cells and cell culture media
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001 005 042